| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |